Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions

Journal of Cell Biology

Volumn 164, Issue 4, 2004, Pages 515-526

  Wang, Jayson ^a   Shiels, Carol ^b   Sasieni, Peter ^c   Wu, Pei Jun ^a   Islam, Suhail A ^b   Freemont, Paul S ^b   Sheer, Denise ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gene density; Major histocompatibility complex; Nuclear organization; PML nuclear body; Transcription

Indexed keywords

NOTCH1 RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID RECEPTOR ALPHA;

ARTICLE; CELL COMPARTMENTALIZATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CHROMOSOME 1; CHROMOSOME 9; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; X CHROMOSOME;

ATP-BINDING CASSETTE TRANSPORTERS; CELL CYCLE; CELL NUCLEUS; CELLS, CULTURED; CHROMOSOMES, HUMAN, X; COLLAGEN TYPE I; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRANUCLEAR INCLUSION BODIES; MALE; MULTIGENE FAMILY; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REGRESSION ANALYSIS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 1242329998     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200305142     Document Type: Article

References (59)

1. Artavanis-Tsakonas, S., K. Matsuno, and M.E. Fortini. 1995. Notch signaling. Science. 268:225-232.
2. Bischof, O., S.H. Kim, J. Irving, S. Beresten, N.A. Ellis, and J. Campisi. 2001. Regulation and localization of the Bloom syndrome protein in response to DNA damage. J. Cell Biol. 153:367-380.
3. Bloch, D.B., J.D. Chiche, D. Orth, S.M. de la Monte, A. Rosenzweig, and K.D. Bloch. 1999. Structural and functional heterogeneity of nuclear bodies. Mol. Cell. Biol. 19:4423-4430.
4. Boehm, U., T. Klamp, M. Groot, and J.C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749-795.
5. Boisvert, F.M., M.J. Hendzel, and D.P. Bazett-Jones. 2000. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148:283-292.
6. Boisvert, F.M., M.J. Kruhlak, A.K. Box, M.J. Hendzel, and D.P. Bazett-Jones. 2001. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152:1099-1106.
7. Borden, K.L. 2002. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22:5259-5269.
8. Borden, K.L., M.N. Boddy, J. Lally, N.J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P.S. Freemont. 1995. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14:1532-1541.
9. Bridger, J.M., H. Herrmann, C. Munkel, and P. Lichter. 1998. Identification of an interchromosomal compartment by polymerization of nuclear-targeted vimentin. J. Cell Sci. 111:1241-1253.
10. Brown, C.J., A. Ballabio, J.L. Rupert, R.G. Lafreniere, M. Grompe, R. Tonlorenzi, and H.F. Willard. 1991. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature. 349:38-44.
11. Brown, K.E., S. Amoils, J.M. Horn, V.J. Buckle, D.R. Higgs, M. Merkenschlager, and A.G. Fisher. 2001. Expression of α- and β-globin genes occurs within different nuclear domains in haemopoietic cells. Nat. Cell Biol. 3:602-606.
12. Bruno, S., F. Ghiotto, F. Fais, M. Fagioli, L. Luzi, P.G. Pelicci, C.E. Grossi, and E. Ciccone. 2003. The PML gene is not involved in the regulation of MHC class 1 expression in human cell lines. Blood. 101:3514-3519.
13. Bustin, M., L. Trieschmann, and Y.V. Postnikov. 1995. The HMG-14/-17 chromosomal protein family: architectural elements that enhance transcription from chromatin templates. Semin. Cell Biol. 6:247-255.
14. Carbone, R., M. Pearson, S. Minucci, and P.G. Pelicci. 2002. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene. 21:1633-1640.
15. Caron, H., B. van Schaik, M. van der Mee, F. Baas, G. Riggins, P. van Sluis, M.C. Hermus, R. van Asperen, K. Boon, P.A. Voute, et al. 2001. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science. 291:1289-1292.
16. Carrel, L., A.A. Cottle, K.C. Goglin, and H.F. Willard. 1999. A first-generation X-inactivation profile of the human X chromosome. Proc. Natl. Acad. Sci. USA. 96:14440-14444.
17. Chubb, J.R., S. Boyle, P. Perry, and W.A. Bickmore. 2002. Chromatin motion is constrained by association with nuclear compartments in human cells. Curr. Biol. 12:439-445.
18. Cremer, T., and C. Cremer. 2001. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2:292-301.
19. Croft, J.A., J.M. Bridger, S. Boyle, P. Perry, P. Teague, and W.A. Bickmore. 1999. Differences in the localization and morphology of chromosomes in the human nucleus. J. Cell Biol. 145:1119-1131.
20. de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 66:675-684.
21. Dietzel, S., K. Schiebel, G. Little, P. Edelmann, G.A. Rappold, R. Eils, C. Cremer, and T. Cremer. 1999. The 3D positioning of ANT2 and ANT3 genes within female X chromosome territories correlates with gene activity. Exp. Cell Res. 252:363-375.
22. Dyck, J.A., G.G. Maul, W.H. Miller, Jr., J.D. Chen, A. Kakizuka, and R.M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 76:333-343.
23. Eils, R., S. Dietzel, E. Bertin, E. Schrock, M.R. Speicher, T. Ried, M. Robert-Nicoud, C. Cremer, and T. Cremer. 1996. Three-dimensional reconstruction of painted human interphase chromosomes: active and inactive X chromosome territories have similar volumes but differ in shape and surface structure. J. Cell Biol. 135:1427-1440.
24. Fabunmi, R.P., W.C. Wigley, P.J. Thomas, and G.N. DeMartino. 2001. Interferon γ regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J. Cell Sci. 114:29-36.
25. Frey, M.R., and A.G. Matera. 1995. Coiled bodies contain U7 small nuclear RNA and associate with specific DNA sequences in interphase human cells. Proc. Natl. Acad. Sci. USA. 92:5915-5919.
26. Fuchsova, B., P. Novak, J. Kafkova, and P. Hozak. 2002. Nuclear DNA helicase II is recruited to IFN-α-activated transcription sites at PML nuclear bodies. J. Cell Biol. 158:463-473.
27. Goddard, A.D., J. Borrow, P.S. Freemont, and E. Solomon. 1991. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 254:1371-1374.
28. Guo, A., P. Salomoni, J. Luo, A. Shih, S. Zhong, W. Gu, and P. Paolo Pandolfi. 2000. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2:730-736.
29. Isogai, Y., and R. Tjian. 2003. Targeting genes and transcription factors to segregated nuclear compartments. Curr. Opin. Cell Biol. 15:296-303.
30. Jensen, K., C. Shiels, and P.S. Freemont. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene. 20:7223-7233.
31. Jolly, C., L. Konecny, D.L. Grady, Y.A. Kutskova, J.J. Cotto, R.I. Morimoto, and C. Vourc'h. 2002. In vivo binding of active heat shock transcription factor 1 to human chromosome 9 heterochromatin during stress. J. Cell Biol. 156:775-781.
32. Kakizuka, A., W.H. Miller, Jr., K. Umesono, R.P. Warrell, Jr., S.R. Frankel, V.V. Murty, E. Dmitrovsky, and R.M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 66:663-674.
33. Kiesslich, A., A. von Mikecz, and P. Hemmerich. 2002. Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J. Struct. Biol. 140:167-179.
34. Koken, M.H., G. Linares-Cruz, F. Quignon, A. Viron, M.K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de The. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 10:1315-1324.
35. LaMorte, V.J., J.A. Dyck, R.L. Ochs, and R.M. Evans. 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95:4991-4996.
36. Lee, K.H., M.Y. Chang, J.I. Ahn, D.H. Yu, S.S. Jung, J.H. Choi, Y.H. Noh, Y.S. Lee, and M.J. Ahn. 2002. Differential gene expression in retinoic acid-induced differentiation ofacute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem. Biophys. Res. Commun. 296:1125-1133.
37. Lehembre, F., S. Muller, P.P. Pandolfi, and A. Dejean. 2001. Regulation of Pax3 transcriptional activity by SUMO-1 modified PML. Oncogene. 20:1-9.
38. Luciani, M.F., F. Denizot, S. Savary, M.G. Mattei, and G. Chimini. 1994. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 21:150-159.
39. Mahy, N.L., P.E. Perry, S. Gilchrist, R.A. Baldock, and W.A. Bickmore. 2002. Spatial organization of active and inactive genes and noncoding DNA within chromosome territories. J. Cell Biol. 157:579-589.
40. Mattson, J.C. 2000. Acute promyelocytic leukemia. From morphology to molecular lesions. Clin. Lab. Med. 20:83-103.
41. Muto, A., M. Kizaki, C. Kawamura, H. Matsushita, Y. Fukuchi, A. Umezawa, T. Yamada, J. Hata, N. Hozumi, K. Yamato, et al. 2001. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF. Leukemia. 15:1176-1184.
42. Negorev, D., and G.G. Maul. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene. 20:7234-7242.
43. Regad, T., and M.K. Chelbi-Alix. 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene. 20:7274-7286.
44. Roix, J.J., P.G. McQueen, P.J. Munson, L.A. Parada, and T. Misteli. 2003. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat. Genet. 34:287-291.
45. Ruggero, D., Z.G. Wang, and P.P. Pandolfi. 2000. The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays. 22:827-835.
46. Seeler, J.S., and A. Dejean. 1999. The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9:362-367.
47. Shiels, C., S.A. Islam, R. Vatcheva, P. Sasieni, M.J. Sternberg, P.S. Freemont, and D. Sheer. 2001. PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 114:3705-3716.
48. Shopland, L.S., M. Byron, J.L. Stein, J.B. Lian, G.S. Stein, and J.B. Lawrence. 2001. Replication-dependent histone gene expression is related to Cajal body (CB) association but does not require sustained CB contact. Mol. Biol. Cell. 12:565-576.
49. Smith, K.P., P.T. Moen, K.L. Wydner, J.R. Coleman, and J.B. Lawrence. 1999. Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific. J. Cell Biol. 144:617-629.
50. Tsukamoto, T., N. Hashiguchi, S.M. Janicki, T. Tumbar, A.S. Belmont, and D.L. Spector. 2000. Visualization of gene activity in living cells. Nat. Cell Biol. 2:871-878.
51. Vallian, S., K.V. Chin, and K.S. Chang. 1998. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol. Cell. Biol. 18:7147-7156.
52. van der Meijden, C.M., D.S. Lapointe, M.X. Luong, D. Peric-Hupkes, B. Cho, J.L. Stein, A.J. van Wijnen, and G.S. Stein. 2002. Gene profiling of cell cycle progression through S-phase reveals sequential expression of gene required for DNA replication and nucleosome assembly. Cancer Res. 62:3233-3243.
53. van Endert, P.M. 1999. Genes regulating MHC class I processing ofantigen. Curr. Opin. Immunol. 11:82-88.
54. Volpi, E.V., E. Chevret, T. Jones, R. Vatcheva, J. Williamson, S. Beck, R.D. Campbell, M. Goldsworthy, S.H. Powis, J. Ragoussis, et al. 2000. Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J. Cell Sci. 113:1565-1576.
55. von Mikecz, A., S. Zhang, M. Montminy, E.M. Tan, and P. Hemmerich. 2000. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J. Cell Biol. 150:265-273.
56. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell. 76:345-356.
57. Williams, R.R., S. Broad, D. Sheer, and J. Ragoussis. 2002. Subchromosomal positioning of the epidermal differentiation complex (EDC) in keratinocyte and lymphoblast interphase nuclei. Exp. Cell Res. 272:163-175.
58. Wu, W.S., Z.X. Xu, and K.S. Chang. 2002. The promyelocytic leukemia protein represses A20-mediated transcription. J Biol Chem. 277:31734-31739.
59. Zheng, P., Y. Guo, Q. Niu, D.E. Levy, J.A. Dyck, S. Lu, L.A. Sheiman, and Y. Liu. 1998. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 396:373-376.